Paper Details

  1. Home
  2. Paper Details

What's New in Topicals for Atopic Dermatitis?

Author: EichenfieldLawrence F, KleinmanElana, LaboradaJennifer, MetterleLauren

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review highlights novel topical treatments for atopic dermatitis (AD) that are in later phases of development, including Janus kinase inhibitors, phosphodiesterase-4 inhibitors, aryl hydrocarbon modulators, and microbiome modulators.
Paper Details　
Original Abstract of the Article :
Atopic dermatitis (AD) is a chronic inflammatory skin condition that can have tremendous impact on quality of life for affected children and adults. First-line therapy for acute management of AD includes topical therapies such as corticosteroids, calcineurin inhibitors, and, more recently, the phosp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464760/

データ提供：米国国立医学図書館（NLM）

Evolving Treatments for Atopic Dermatitis: New Horizons in Topical Therapies

This study explores the exciting advancements in topical treatments for atopic dermatitis (AD), a chronic inflammatory skin condition. Think of a camel caravan facing a harsh desert environment, with skin irritation and discomfort hindering its journey. These topical therapies are like a soothing balm, providing relief and restoring the camels' skin health.

A New Generation of Topical Therapies: Targets and Innovations

The study highlights the growing number of novel topical therapies targeting various aspects of AD pathogenesis, including Janus kinase inhibition, phosphodiesterase-4 inhibition, aryl hydrocarbon modulation, and microbiome modulation. This is like a caravan exploring new pathways and resources to overcome the challenges of the desert environment.

Hope for Improved Treatment Outcomes

The study suggests that these new therapies hold promise for improved treatment outcomes for patients with AD. It emphasizes the need for further research to evaluate the long-term safety and efficacy of these innovative approaches. It's a journey towards a better future for those suffering from AD, seeking a path towards healing and comfort.

Dr. Camel's Conclusion

This study is a testament to the relentless pursuit of better treatments for atopic dermatitis. It's like a camel caravan constantly seeking a more comfortable and manageable journey through the desert, always striving for improved health and well-being.

Date :
  1. Date Completed 2022-09-13
  2. Date Revised 2022-10-31
Further Info :

Pubmed ID

36048410

DOI: Digital Object Identifier

PMC9464760

Related Literature

Article Analysis
・Effects of tapinarof topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.